Genomic coordinate (human 10:104,031,286 COL17A1) & (mouse 19:47,634,783 Col17a1).
Cytoband (human 10q25.1 COL17A1) & (mouse 19qC3 Col17a1).
Here I present: “Generalized Atrophic Benign Epidermolysis Bullosa“, Victor McKucick, Mendelian Inheritance in Man’, 1966. (GABEB) icd10=Q81.9
General Atrophic Benign Epidermolysis Bullosa (GABEB) is a milder, genetic form of Junctional EB, causing fragile skin that blisters from minor trauma, often improving with age, but still featuring blisters, nail/hair issues, and specific skin growths, linked to mutations in the COL17A1 gene, with management focusing on symptom control and skin protection.
What it is:
Genetic Skin Fragility: GABEB is a type of Epidermolysis Bullosa (EB), a disorder where skin layers don’t stick together, leading to blistering.Milder Form: “Benign” indicates a more favorable prognosis compared to severe EB types, with blistering often improving after infancy.
Key Characteristics:
Blisters: Chronic blistering from birth, especially on hands and feet, due to friction.Nail Dystrophy: Nails can become abnormal or lost.Hair Loss (Alopecia): Can occur.Dental Issues: Abnormal teeth.Skin Growths: Large, benign (non-cancerous) moles (nevi) may form where blisters healed.
Causes:
Caused by genetic mutations, specifically in the COL17A1 gene, affecting the proteins that anchor skin layers.
Management & Outlook:
No Cure: Currently, there’s no cure for EB, but treatments manage symptoms.Supportive Care: Focuses on preventing skin trauma through careful handling, wound care, bandaging, and pain management.Favorable Prognosis: Generally, GABEB has a better outlook than severe EB forms, though it still requires lifelong management.
There is evidence that generalized atophic-benign epidermolysis-bullosa is caused by mutation in the collagen-XVII type-A1 (COL17A1) gene encoded on genomic coordinate 10:104,031,286 and cytoband 10q25.1 in humans.
